Inventor · disambiguated record
Martine Van Vugt
Also filed as: VAN VUGT MARTINE
13 granted patents·8 pending applications·462 citations·filing 2005–2023
94Inventor score
Top patents by PatentIndex Score
21 records- 0198US7829673B2Antibodies against CD38 for treatment of multiple myelomaGENMAB AS·Filed 2006·Granted Nov 9, 2010·148 cites·29 claims
- 0297US7563441B2Anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2005·Granted Jul 21, 2009·94 cites·34 claims
- 0397US7501496B1Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2005·Granted Mar 10, 2009·87 cites·26 claims
- 0494US9040050B2Combination treatment of CD38-expressing tumorsVAN DE WINKEL JAN·Filed 2007·Granted May 26, 2015·39 cites·68 claims
- 0593US7868141B2Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2008·Granted Jan 11, 2011·21 cites·23 claims
- 0691US7824684B2Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2010·Granted Nov 2, 2010·14 cites·20 claims
- 0790US9102733B2Anti-OX40L antibodiesENDL JOSEPH·Filed 2010·Granted Aug 11, 2015·20 cites·17 claims
- 0890US7807158B2Antibodies against IL-13 receptor alpha1 and uses thereofROCHE PALO ALTO LLC·Filed 2006·Granted Oct 5, 2010·19 cites·9 claims
- 0988US7754867B2Nucleic acid molecules encoding anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2009·Granted Jul 13, 2010·8 cites·42 claims
- 1086US9187565B2Antibodies against CD38 for treatment of multiple myelomaDE WEERS MICHEL·Filed 2010·Granted Nov 17, 2015·8 cites·19 claims
- 1184US2024228662A9Antibodies against cd38 for treatment of multiple myelomaGENMAB AS·Filed 2023·Application pending·0 cites
- 1282US2024165226A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2023·Application pending·0 cites
- 1377USRE43568EAnti-P-selectin antibodiesGRAUS YVO·Filed 2011·Granted Aug 7, 2012·3 cites·141 claims
- 1473US2020114000A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2019·Application pending·0 cites
- 1572US2015231235A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2014·Application pending·0 cites
- 1669USRE44359ENucleic acid molecules encoding anti-P-selectin antibodiesGRAUS YVO·Filed 2012·Granted Jul 9, 2013·1 cites·169 claims
- 1767US2020283542A1Antibodies against cd38 for treatment of multiple myelomaGENMAB AS·Filed 2020·Application pending·0 cites
- 1860USRE44389EMethods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2012·Granted Jul 23, 2013·0 cites·81 claims
- 1954US2016130362A1Antibodies against cd38 for treatment of multiple myelomaGENMAB AS·Filed 2015·Application pending·0 cites
- 2047US2009076249A1Antibodies against CD38 for treatment of multiple myelomaDE WEERS MICHEL·Filed 2007·Application pending·0 cites
- 2142US2011086026A1Antibodies against il-13 receptor alpha 1 and uses thereofENDL JOSEF·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martine Van Vugt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →